Ameritas Investment Partners, Inc. Harpoon Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.78 - $5.02 $1,961 - $5,532	-1,102 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$17.65 - $24.16 $8,207 - $11,234	465 Added 73.0%	1,102 $23,000
Q4 2019 Feb 13, 2020	BUY	$12.94 - $20.58 $5,525 - $8,787	427 Added 203.33%	637 $9,000
Q1 2019 May 15, 2019	BUY	$9.47 - $17.01 $1,988 - $3,572	210 New	210 $2,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.